These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice. Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464 [TBL] [Abstract][Full Text] [Related]
8. Alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injury. Lijnen HR; Van Hoef B; Dewerchin M; Collen D Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1488-92. PubMed ID: 10845862 [TBL] [Abstract][Full Text] [Related]
9. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667 [TBL] [Abstract][Full Text] [Related]
10. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis. Kitching AR; Turner AL; O'Sullivan KM; Dewerchin M; Lijnen HR J Thromb Haemost; 2003 Sep; 1(9):1992-9. PubMed ID: 12941042 [TBL] [Abstract][Full Text] [Related]
11. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. Carpenter SL; Mathew P Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice. Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014 [TBL] [Abstract][Full Text] [Related]
13. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609 [TBL] [Abstract][Full Text] [Related]
14. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury. Lijnen HR Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512 [TBL] [Abstract][Full Text] [Related]
15. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report. Mohammed BAB J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960 [TBL] [Abstract][Full Text] [Related]
16. Alpha2-antiplasmin on cardiovascular diseases. Matsuno H Curr Pharm Des; 2006; 12(7):841-7. PubMed ID: 16515500 [TBL] [Abstract][Full Text] [Related]
17. X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin. Law RH; Sofian T; Kan WT; Horvath AJ; Hitchen CR; Langendorf CG; Buckle AM; Whisstock JC; Coughlin PB Blood; 2008 Feb; 111(4):2049-52. PubMed ID: 18063751 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin. Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524 [TBL] [Abstract][Full Text] [Related]
19. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics. Christensen U; Bangert K; Thorsen S FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567 [TBL] [Abstract][Full Text] [Related]
20. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]